Mead Johnson Nutrition CO  

(Public, NYSE:MJN)   Watch this stock  
Find more results for MJN
+0.60 (0.84%)
Real-time:   11:45AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 71.50 - 72.22
52 week 65.53 - 94.40
Open 71.62
Vol / Avg. 371,917.00/2.44M
Mkt cap 13.24B
P/E 26.69
Div/yield 0.41/2.30
EPS 2.69
Shares 184.80M
Beta 1.41
Inst. own 99%
Jan 26, 2017
Q4 2016 Mead Johnson Nutrition Co Earnings Release (Tentative) - 9:30AM EST - Add to calendar
Jan 26, 2017
Q4 2016 Mead Johnson Nutrition Co Earnings Call (Tentative) Add to calendar
Nov 15, 2016
Mead Johnson Nutrition Co at Morgan Stanley Consumer Conference
Oct 27, 2016
Q3 2016 Mead Johnson Nutrition Co Earnings Call - Webcast
Oct 27, 2016
Q3 2016 Mead Johnson Nutrition Co Earnings Release
Sep 7, 2016
Mead Johnson Nutrition Co at Barclays Global Consumer Staples Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 15.85% 16.10%
Operating margin 24.34% 23.00%
EBITD margin - 27.44%
Return on average assets 14.50% 16.89%
Return on average equity - -
Employees 7,660 -
CDP Score - 97 B


2701 Patriot Blvd Fl 4
GLENVIEW, IL 60026-8039
United States - Map
+1-847-8322420 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.

Officers and directors

Peter Kasper Jakobsen President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Michel M.G. Cup Chief Financial Officer, Executive Vice President
Age: 46
Bio & Compensation  - Reuters
Charles M. Urbain Chief Operating Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
Patrick M. Sheller Senior Vice President, General Counsel, Secretary
Age: 54
Bio & Compensation  - Reuters
James E. Shiah Senior Vice President, Corporate Controller
Age: 56
Bio & Compensation  - Reuters
James Jeffrey Jobe Senior Vice President - Technical Operations
Age: 56
Bio & Compensation  - Reuters
Graciela Monteagudo Senior Vice President, President for the Americas and Global Marketing
Age: 49
Bio & Compensation  - Reuters
Ian Eric Ormesher Senior Vice President- Global Human Resources
Age: 53
Bio & Compensation  - Reuters
Christopher R. Stratton Senior Vice President and President , Asia
Age: 62
Bio & Compensation  - Reuters
Dirk Hondmann Ph.D. Chief Scientific Officer
Age: 52
Bio & Compensation  - Reuters